Clinicians currently use different low-weight cut-offs both to diagnose anorexia nervosa (AN) and to determine AN severity in adolescent girls. The purpose of this study was to evaluate the clinical utility of existing cut-offs and severity criteria by determining which are most strongly associated with risk for low bone mineral density (BMD). Height adjusted BMD Z scores were calculated for 352 females: 262 with AN and 90 healthy controls (controls) (12-20.5 years), using data from the BMD in Childhood Study, for the lumbar spine, whole body less head, and total hip. For most cutoffs used to define low weight (5th or 10th BMI percentile, BMI of 17.5 or 18.5, and 85 or 90% of median BMI), AN had lower BMD Z scores than controls. AN at >85 or >90% expected body weight for height (EBW-Ht) did not differ in BMD Z scores from controls, but differed significantly from AN at 85 or 90% EBW-Ht. Among AN, any amenorrhea was associated with lower BMD. 
from those with full syndrome AN in eating pathology or recovery rates (Eddy, Celio Doyle, Hoste, et al., 2008; Smink, van Hoeken, Oldehinkel, & Hoek, 2014) . Following implementation of the revised criteria, lifetime prevalence of AN among female adolescents increased by 50%, ranging from 0.8 to 1.7% (Mustelin, Silen, Raevuori, et al., 2016; Nagl, Jacobi, Paul, et al., 2016; Smink et al., 2014) . Although the broader definition allows for detection of cases that may have been previously missed, operationalizing "significantly low weight" in order to confer a diagnosis of AN continues to be challenging in clinical practice (Golden et al., 2015; Knoll, Bulik, & Hebebrand, 2011; Sawyer, Whitelaw, Le Grange, et al, 2016; Thomas, Eddy, Murray, et al., 2015; Thomas, Roberto, & Brownell, 2009) . Importantly, the impact of revised weight and menstrual criteria on clinical outcomes, such as bone mineral density (BMD), has not been assessed in adolescent girls. As adolescence is a critical time for bone accrual (Halmi, Casper, Eckert, et al., 1979; Katzman, 2005) , determining effects of revised AN criteria on bone endpoints is key to (i) better understanding associated medical sequelae, and (ii) developing clear and empirically informed treatment guidelines designating when to refer low-weight patients for dual energy X-ray absorptiometry (DXA) scanning for BMD.
To guide treatment planning (American Psychiatric Association, 2013), DSM-5 includes new severity specifiers for adults with AN that categorize the disorder as "mild," "moderate," "severe," or "extreme" based on World Health Organization (WHO) BMI classifications. No study to date has evaluated their relationship to severity of medical sequelae, such as BMD. Furthermore, it is unclear whether these categories are relevant for adolescents, whose expectations for absolute BMI increase with age. The Society for Adolescent Health and Medicine (SAHM) recommends calculating both the percent median BMI (%mBMI)-a comparison of the individual's BMI to a reference population-and the BMI z scores (degree of deviation between an individual's BMI and the mean) to evaluate severity of malnutrition (Golden, Katzman, Sawyer, et al., 2015) . Therefore, the SAHM's alternative lowweight severity ratings, based on %mBMI and BMI z-scores, may be more appropriate for youth AN.
To examine the clinical utility of various definitions for determining low-weight status in adolescent girls with AN, we evaluated common low-weight definitions and severity categories as suggested by the DSM-IV, DSM-5, WHO, and the SAHM (Tables 1and 2) , in relation to BMD. We also investigated amenorrhea as a moderator of BMD across low-weight parameters, as disruptions in estrogen status are known determinants of BMD (Solmi, Veronese, Correll, et al., 2016) . Reduced BMD is a major morbidity of AN and early detection and weight gain may help reduce fracture risk (Faje, Fazeli, Miller, et al., 2014; Katzman, 2005; Misra, Aggarwal, Miller, et al., 2004; Robinson, Aldridge, Clark, et al., 2016) . As such, our overarching aim was to allow for risk analysis for low BMD in adolescent girls with AN, by combining diagnostic and severity classifications with objective clinical data.
| M E T H O D S

| Participants
Participants in the current study (262 with AN; 90 healthy controls)
were taken from a sample of participants 12-20.5 years old screened for past or current AN studies conducted by the Neuroendocrine and Pediatric Endocrine units at Massachusetts General Hospital between 2002 and 2016 (Faje et al., 2014; Misra, Katzman, Miller, et al., 2011; Misra, McGrane, Miller, et al., 2009; Misra, Prabhakaran, Miller, et al., 2008) . All those who met criteria for AN and had a DXA scan were a Because so few patients were classified as severe using %mBMI (n 5 8), we grouped those identified as moderate and severe together for analyses.
We chose not to eliminate these eight participants as this would have led to a reduction in the number of participants in the severe/extreme category for other severity systems, and resulted in an underrepresentation of the severity of low BMD using these other systems.
included in the analyses in the AN group. All those who met criteria for normal-weight controls and had a DXA scan were similarly included in the analyses as controls. Comparisons of BMD in a subset of AN versus controls have been previously reported, but not in relation to diagnostic and severity classifications (Faje et al., 2014; Misra et al., 2008 Misra et al., , 2009 Misra et al., , 2011 . Participants were recruited through advertisements and referrals from eating disorder centers and regional practitioners; 98.8%
of AN participants and 93.4% controls were Caucasian. A study psychologist/psychiatrist confirmed the AN diagnosis per DSM-IV-TR or DSM-5 (depending on whether assessments were done before or after the 2013 publication of DSM-5) by reviewing clinical data and conducting a clinical interview including items from the Structured Clinical
Interview for DSM-IV (First, Spitzer, Gibbon, Williams, 1997) . To establish significantly low weight, participants were required to meet 2 of three criteria (%mBMI, percent expected body weight (%EBW) for height, or %EBW for age <90%). Controls were defined as having a BMI between the 10th-90th percentiles, eumenorrheic (when postmenarchal), with no lifetime history of eating disorders. Exclusion criteria for both groups included use of medications and concurrent diseases that may affect bone within 3 months of study participation (Golden et al., 2015) .
| Clinical protocol
The Partners HealthCare Institutional Review Board approved this study. Participants were weighed on a calibrated scale wearing a hospital gown, and height measured in triplicate on a stadiometer. Tanner stage, menarchal age, presence of amenorrhea (absence of menarche in those 15 years or absence of menstruation for three consecutive months preceding the study in post-menarchal girls), and bone age (from an X-ray of the left hand and wrist) were evaluated by a study endocrinologist (Greulich & Pyle, 1959) . We obtained information regarding duration since AN diagnosis at the time of the study visit, but could not reliably determine the total illness duration due to the limitations of self-reported information about AN onset. Whole body less head (WBLH), lumbar spine (L1-L4), and total hip areal BMD were determined using DXA (Hologic 4500 A, Waltham, MA). Age, sex, and race specific Z scores were calculated using the Longitudinal Bone Density in Childhood Study (Zemel, Kalkwarf, Gilsanz, 2011 (Kuczmarski, Ogden, Grummer-Strawn, et al., 2000) . Post-menarchal participants were further classified based on duration of amenorrhea: no amenorrhea, <6 months, and 6 months without menstruation, and also no amenorrhea, <1 year, and 1 year without menstruation, (referring to consecutive months of amenorrhea). Further, we examined outcomes based on presence of primary or secondary amenorrhea. While numbers of controls remained the same at any site, numbers of AN participants in each group changed (as expected) depending on the low weight parameter (Tables 1 and 2 ).
| Statistical analyses
We conducted analyses using JMP Statistical Discovery Software, v11PRO and SPSS v23. We used analysis of variance or the KruskalWallis test to compare differences across groups (depending on data distribution), followed by the Tukey-Kramer or Steel-Dwass test, respectively to adjust for multiple comparisons. The Fisher's-Exact test with Bonferroni's correction was used to compare proportions across groups. We conducted an ANOVA with contrast weights for each severity classification scheme (i.e., BMI, %mBMI, and BMI Z scores) to determine if BMD decreased linearly corresponding to increased AN severity. We followed up these ANOVAs with planned pairwise comparisons of BMD between individual severity groups within each classification scheme. Finally, we ran regression models to determine whether amenorrhea status and menarchal age modified the impact of weight criteria on BMD in AN. We first ran separate regression models for each low-weight parameter dichotomized per the cut-off (e.g., BMI of or >17.5) and included the duration of amenorrhea as a moderator (dichotomized as amenorrhea > or 6 months or 1 year). In an expanded model, we also included menarchal age (a known determinant of BMD) in this analysis to determine whether effects of low weight or duration of amenorrhea on BMD were independent of menarchal age. Table 1 ). Similarly, for both BMI cut-offs, a larger proportion of participants in both AN groups had BMD Z-scores <21 compared with controls, but the proportion did not differ across AN groups (Table 4) .
| R E S U L T S
| BMD Z-scores based on BMI percentiles
Regardless of the BMI percentile cut-off used for diagnosis, compared Table 1 ). For the 5th and 10th BMI percentile cut-offs, a larger proportion of participants in both AN groups had BMD Z scores < 21 compared with controls, and the proportion did not differ across AN groups (Table 4) .
| BMD Z-scores based on percent median BMI
Regardless of the percent median BMI cut-off used for diagnosis, compared with controls, AN participants had lower BMD Z scores and a larger proportion of AN participants had BMD Z scores < 21 for all sites (with no difference across AN groups). AN groups defined according to %mBMI (85% or >85%, and 90% vs. >90%) had lower BMD Z scores at all sites than controls. AN participants with %mBMI above the respective cutoff had BMD Z scores intermediate between those
with %mBMI below the cut-off and controls. The difference between AN groups was only significant for spine and hip BMD Z scores using 85%mBMI as the cut-off criterion (Figure 1 , Supporting Information Table 1 ). Data were similar overall for the proportion of participants with BMD Z-scores <-1 (Table 4) .
3.1.4 | BMD Z-scores based on percent expected body weight for height AN participants at 85% or 90% EBW-Ht had lower BMD Z scores overall and a larger proportion of these participants had a Z score of <21 compared with AN participants at >85% or >90% EBW-Ht respectively, as well as controls. Importantly, AN participants with EBW-Ht >85% or >90% did not differ from controls for BMD Z scores.
BMD Z scores for WBLH and spine did not differ between AN participants with %EBW-Ht > 85% and controls, although hip BMD Z scores were lower in those with %EBW-Ht > 85% compared to controls (Supporting Information Table 1 ). AN participants with %EBW-Ht 85%
had lower BMD Z scores at the WBLH, spine, and hip than those with %EBW-Ht > 85% and controls (Figure 1 , Supporting Information Table   1 ). Similarly, AN participants with %EBW-Ht > 90% did not differ from controls for BMD Z-scores at all sites, whereas AN participants with %EBW-Ht 90% had lower BMD Z scores at the WBLH, spine, and hip than those with %EBW-Ht > 90% and controls (Figure 1 , Hip BMD Z-score 20.8 6 0.06 0.1 6 0.1 <.0001
Mean 6SEM *Wilcoxon test is used for nonparametric samples.
Supporting Information Table 1 ). Data were similar for differences across groups for the proportion with BMD Z-scores <-1 (Table 4) .
3.1.5 | Summary of results for BMD across low-weight cut-offs for AN EBW-Ht was the only low-weight parameter to differentiate AN participants based on BMD Z scores, such that AN participants below 85 or 90% EBW-Ht had significantly lower BMD Z scores than AN above these cut-offs and controls. Further AN groups above these cut-offs were the only AN participants who did not differ in BMD Z scores from controls. For all other parameters (absolute BMI, BMI percentiles, and %mBMI median cut-offs), there was no difference in BMD Z scores between AN participants above and below tested parameters, and all AN groups (regardless of whether they were above or below the tested cut-off) had lower BMD Z scores than controls. Table 2 ). However, no betweengroup differences emerged at WBLH or spine.
FIG URE 1 Bone mineral density (BMD) Z scores of whole body less head (WBLH), lumbar spine (spine), and total hip skeletal sites across tested low-weight parameters in participants with Anorexia Nervosa (AN) and healthy controls (C). Panel 1: BMD Z scores of AN participants based on body mass index (BMI) cut-offs 17.5 and 18.5 (gray bars), and controls (white bars). BMD Z scores at all sites are lower in both groups of AN participants compared with controls. However, within participants with AN, having a BMI less than or >17.5 or 18.5 does not predict lower BMD Z scores. *p < .05. Panel 2: BMD Z scores of AN participants based on BMI percentile cut-offs; 5th and 10th (gray bars) and controls (white bars). BMD Z scores at all sites are lower in both groups of AN participants compared with controls. However, within participants with AN, those with a BMI percentile less than the 10th percentile have significantly lower total hip BMD Z scores than those with a BMI percentile above the 10th percentile. *p < .05. Panel 3: BMD Z scores of AN participants based on median BMI (mBMI) cut-offs 85 and 90% (gray bars) and controls (white bars). BMD Z scores at all sites are lower in both groups of AN participants compared with controls. Within AN participants, those with mBMI > 85% have higher total hip and lumbar spine BMD Z scores than those with mBMI 85%, and AN participants with mBMI > 90% have higher total hip BMD Z scores than those with mBMI 90%. *p < .05. 
| BMI-Z scores (SAHM severity categories)
ANOVA contrast demonstrated a monotonic decrease in BMD Z scores across all three sites concomitant with increasing severity of BMI Z scores (p < .0001 for all). In follow-up pairwise comparisons, severe AN had lower spine and hip BMD Z scores than mild AN ( Figure   2 , Supporting Information Table 4) , with no differences in WBLH.
| Moderating effect of duration since diagnosis
In a regression model that included (i) the low weight parameter of interest dichotomized per the cut-off used to describe low weight, and
(ii) duration since diagnosis, we found that in each of these models, duration since diagnosis inversely predicted BMD Z scores at all sites (p .03). Adding duration since diagnosis to these models did not change our results for the effect of the low weight parameter of interest on BMD Z scores. EBW-Ht was consistently the only low-weight parameter to differentiate AN participants based on BMD Z scores, such that AN participants 85 or 90% EBW-Ht had significantly lower BMD Z scores than AN above these cut-offs and controls (p < 0.0001).
The only change was that spine BMD Z scores were lower in those with %mBMI 85% versus those with %mBMI > 85% (p 5 0.04).
| Moderating effect of amenorrhea
Regardless of duration of amenorrhea (6 months . BMD Z scores at the lumbar spine and total hip are lower in anorexia nervosa (AN) participants at <80% (moderate and severe), 80-90% (mild) and >90% mBMI than controls, and at the WBLH in AN participants <80% (moderate and severe) and 80-90% (mild) than controls. AN participants with moderate/severe malnutrition (<80% mBMI) have lower lumbar spine BMD Z scores than participants with mild malnutrition (>80-90% mBMI). *p < .05. Panel 3: BMD Z scores, based on severity of malnutrition classified according to BMI Z scores (SAHM). BMD Z scores at all sites are lower in AN participants with BMI Z scores 23 (severe), between 22 and 22.9 (moderate) or between 21 to 21.9 (mild) malnutrition compared to controls, and at the lumbar spine and total hip in AN participants with BMI Z scores >21 compared to controls. AN participants with severe malnutrition (BMI Z scores 23) have lower lumbar spine and total hip BMD Z scores than those with mild malnutrition (BMI Z scores between 21 to 21.9) and AN participants with BMI Z scores >21.
In a regression model that included (i) the low weight parameter of interest dichotomized per the cut-off used to describe low weight, and (ii) duration of amenorrhea (categorized as amenorrhea >6 months or 6 months, eumenorrhea, and controls), amenorrhea duration did not predict lower BMD measurements. However, in this model, both groups of amenorrheic AN participants consistently had lower BMD of the WBLH (p < 0.05) than the AN girls with eumenorrhea and controls, independent of the weight cut-off assessed. Our results were similar when we used amenorrhea > or 1 year as the variable of interest.
When we included both amenorrhea duration and menarchal age in this regression model that also included the low weight parameter of interest, older age of menarche emerged as a consistent inverse predictor of lower BMD Z scores (p < 0.05) (details not shown).
| DISCUSSION
We evaluated the clinical utility of commonly applied cut-offs for significantly low weight used to diagnose and determine the severity of AN by establishing their relation to BMD. Female adolescents were classified according to seven schemes, including parameters suggested by DSM-IV, DSM-5, the WHO, and SAHM. Our findings support existing literature (Grinspoon, Thomas, Pitts et al., 2000; Misra et al., 2004; Solmi et al., 2016) showing that for all lowweight cutoffs, girls with AN have lower BMD across all skeletal sites compared to controls, increasing their risk for future fractures.
However, our results are unique because they demonstrate that low BMD is a complication even for girls above commonly utilized low-weight cut-offs, lending support to the relaxed criteria introduced in DSM-5 (American Psychiatric Association, 2000) and WHO (Knoll, Bulik, & Hebebrand, 2011) . Thus, our data demonstrate the very significant impact of even mild severity AN on BMD.
Because early detection and treatment of low BMD can lead to better prognosis for bone (Misra et al., 2008) , these data encourage clinicians to consider bone assessments for all adolescent girls with AN and those with atypical AN. This information may be acutely relevant when engaging patients/families in eating-disorder treatment. Explaining that bone health may already be compromised may mobilize family urgency and enhance motivation for recovery (Lock & Le Grange, 2012) . (Golden, Yang, Jacobson, et al., 2012) . This may reduce the capability of cut-offs based on %mBMI to pick up medical morbidity associated with AN, and that %EBW-Ht may better estimate nutritional status in tall girls. Overall, our data suggest that EBWHt 90% may be a uniquely important low-weight parameter in identifying those AN patients most at risk for low BMD and associated complications, and our results did not change after adjusting for duration since diagnosis. Therefore, we recommend practitioners calculate this parameter in adolescent girls with AN or atypical AN, and limit BMD assessments to those with EBW-Ht 90%.
| Bone density across AN severity categories
Girls with AN had lower BMD across all 4 newly proposed DSM-5 AN severity categories, however, we did not find differences between these classifications except that those with a BMI <17.0 (moderately or severely malnourished) showed lower hip BMD scores than those with a BMI 17. Similarly, participants with AN organized by the SAHM severity classification scheme also had lower BMD Z-scores across all skeletal sites than controls regardless of whether %mBMI or BMI Z scores were applied.
However, the SAHM severity scheme had greater utility in stratifying BMD risk, particularly with BMI Z scores. Participants with BMI Z scores 23 (severe) had lower spine and hip BMD Z scores than those with BMI Z scores between 21.0 and 21.99 (mild) and those with BMI Z-scores >21 (but not between 22 and 22.99, i.e., moderate malnutrition), suggesting that patients in this range may be at higher risk for extreme bone loss. Further, ANOVA analyses revealed that BMD decreases in an expected linear fashion corresponding to increased severity defined by BMI Z scores. SAHM low-weight recommendations also advise that clinicians assess the extent and rate of weight loss.
Although we could not assess this with our data, inclusion of such analyses may reveal further distinctions between severity classifications.
Given that the SAHM BMI Z score severity scheme showed more distinctions between severity classifications using follow-up pairwise comparisons, we recommend practitioners employ the SAHM classifications based on BMI Z scores when determining AN severity for adolescent girls, at least in the United States. This is particularly important for younger adolescents who are still growing, given that BMI is expected to change with increasing age.
| Effect of Menstrual Status
Amenorrhea moderated BMD scores in AN such that those with amenorrhea of any duration had lower WBLH BMD Z-scores than eumenorrheic AN. However, regardless of duration of amenorrhea or menstrual status, all groups of AN participants had lower BMD Z scores at the spine and hip than controls. Consistent with results from a recent meta-analysis (Mehler & MacKenzie, 2009; Solmi et al., 2016) , these findings indicate that duration of amenorrhea is a severity marker for low weight and bone health for the WBLH, and emphasize the importance of early intervention to minimize bone loss. However, the spine and hip may be impacted regardless of menstrual status. Further, higher menarchal age was a negative determinant of BMD independent of low weight and amenorrhea duration, consistent with previous reports (Misra et al., 2004) .
| Limitations
Power may have been limited for certain comparisons, as we did not have data across all skeletal sites for all participants. Further, AN participants were slightly older than controls; however, this should have made comparisons more conservative, because older adolescents would have accrued more bone than younger participants. BMD and bone mineral content vary across age, race, and sex (Kalkwarf, Zemel, Gilsanz, et al., 2007; Misra, Ackerman, Bredella, et al., 2016; Zemel et al., 2011) , and our sample was entirely female adolescents and mostly Caucasian. Thus, replication of findings in different racial/ethnic groups and males is required, and our data may not apply to adults.
Although we obtained information about duration since AN diagnosis, the age of AN onset was based on self-report. Thus, we did not have a reliable way to calculate total illness duration, especially for younger participants. Further, we do not have information regarding participant smoking status, level of physical activity, or use of psychotropic medication, all of which could influence results. Finally, our study was crosssectional, preventing examination of long-term effects of low weight on bone.
| C O NC LU S I O N
Individuals with AN have lower WBLH, spine, and hip BMD than controls across common low-weight parameters, and even when the condition is less severe. In fact, this difference is observed also for participants above tested low-weight cut-offs, indicating that BMD is >90% EBW-Ht, should be referred for a DXA scan. Further, categorizing adolescent girls with AN using the SAHM BMI Z score severity ratings has the greatest utility for identifying risk for low BMD. This is particularly so because absolute BMI (used for DSM-5 severity ratings) continues to increase with increasing age during adolescence. Future studies should examine percent and rate of weight loss in relation to bone health and take a longitudinal approach to examining bone health in AN classified per low-weight parameters.
